Introduction
============

Despite extensive cognitive specializations and evolutionary changes in brain morphology in humans ([@evv132-B35]; [@evv132-B40]; [@evv132-B9]), roughly 98.5% of DNA coding regions is identical to our closest living relatives, chimpanzees ([@evv132-B6]; [@evv132-B36]). Early evidence demonstrating a high degree of similarity between human and chimpanzee protein sequences led [@evv132-B25] to suggest that the substantial differences in the behavioral phenotype between these two species are not only the result of changes to the amino acid sequences of proteins but instead may arise from the differential regulation of homologous genes. Therefore, it may be that differential regulation of molecular expression is responsible for the most profound phenotypic divergence between humans and chimpanzees instead of the biochemical changes implicit in sequence evolution. The fact that the human and chimpanzee proteomes differ only by about 50,000 changes in amino acid sequence ([@evv132-B6]) reinforces the plausibility of King and Wilson's proposal. Indeed, protein--protein interactions, the foundation of cellular molecular function, are potentially affected by changes in amino acid sequence, and therefore alterations to DNA coding regions may have deleterious effects on the biochemical functions of a protein ([@evv132-B14]; [@evv132-B52]; [@evv132-B11]). Accordingly, the human behavioral phenotype may have arisen, in part, through changes in the expression levels of gene transcripts and proteins, while keeping the amino acid sequences of proteins relatively stable.

Empirical evidence has revealed profound differences in the regulation of transcriptional expression in the human brain compared with that of the chimpanzee. A survey of promoter sequences found many more *cis*-regulatory sequences were enriched for positive selection in humans compared with chimpanzees and may target the expression of genes supporting neural development and glucose metabolism in particular ([@evv132-B17]). Additionally, intermolecular gene regulation through *trans*-regulatory elements, specifically microRNAs (miRNAs) or transcription factors, is known to cause divergent patterns of transcript expression between humans and chimpanzees. Novel miRNAs may have emerged within the human lineage as key translational regulators ([@evv132-B2]; [@evv132-B19]), and miRNA-mediated gene silencing is enhanced in the human brain compared with other primates ([@evv132-B45]). Furthermore, transcription factor sequences have been shown to evolve more rapidly in humans compared with chimpanzees ([@evv132-B5]). When examining the expression of transcripts across brain regions, humans display unique patterns of coexpression compared with chimpanzees, which may underlie species-specific changes in regional connectivity and network dynamics ([@evv132-B31]; [@evv132-B27]).

Despite our knowledge of the regulatory mechanisms affecting transcription, it is not well understood how the expression levels of transcripts correspond to downstream protein abundances. The rates of transcription and translation and the differential degradation rates of mRNA and proteins are processes that ultimately affect protein abundance, and each of these steps is governed by strict regulation ([@evv132-B26]; [@evv132-B7]). Recent studies measuring molecular expression in human or chimpanzee cell lines have found that transcript abundance predicts between 4% and 50% of protein expression ([@evv132-B39]; [@evv132-B24]; [@evv132-B53]). However, because these studies were performed in undifferentiated cell culture to control for perturbations that cause measurement error, it is not known whether the relationship between transcript and protein abundance remains similar in differentiated tissue or whether tissue differentiation confounds this relationship further. Moreover, it is unclear to what extent the discordance of expression levels between transcripts and proteins affects the biological signals obtained from enrichment analyses on brain tissue from two closely related species.

In this study, we explore the relationship between the expression of gene transcripts to proteins of humans and chimpanzees in two regions of the brain, the anterior cingulate cortex (ACC) and the caudate nucleus (CN). We used RNA-Seq and ultraperformance liquid chromatography coupled with high-resolution accurate mass tandem mass spectrometry (LC/MS/MS) on the same samples of brain tissue for the identification and quantification of transcripts and proteins, respectively. The ACC is a region of the neocortex that is among the most enlarged in human evolution ([@evv132-B18]; [@evv132-B10]). Activity in the ACC is involved in cognitive processes, including executive control ([@evv132-B22]), attention ([@evv132-B33]), and visual perception of spatial relationships among objects ([@evv132-B10]). The CN is a subcortical structure of the basal ganglia, which contains a large population of medium spiny neurons that primarily release the inhibitory neurotransmitter GABA, unlike the predominantly glutamatergic neurons of the cerebral cortex ([@evv132-B46]). The CN is implicated in the execution of movement, goal-directed action, memory, learning, and the production of speech in humans ([@evv132-B20]; [@evv132-B34]). These regions of interest were selected for this study as they are expected to have a large degree of divergence in molecular expression between the two species due to their roles in human-specific cognition, but the molecular expression profiles between the two regions may differ considerably as components of the neocortex and basal ganglia.

Our study had two main objectives. First, we tested the hypothesis that the relationship between the expression of transcripts and proteins differs by species and region of the brain. We found lower correlations in the abundances of gene transcripts to proteins than previous studies utilizing undifferentiated cell lines, suggesting that the relationship in the expression of these molecules is particularly divergent in brain tissue of humans and chimpanzees. Second, we examined whether differential enrichment analyses of transcripts and proteins revealed the same biological signals between the two species. To address these issues, we performed differential expression analyses on the complete transcriptional and proteomic data sets, but we also constructed a data set where transcripts were paired with their protein products, creating a 1:1 ratio of transcripts and proteins. This strategy enabled us to determine whether differences in biological signals were the result of the greater molecular coverage of transcriptional analyses. Although some categories of biological function were differentially expressed (DE) in both types of molecules, we found that there were certain signals to which transcripts or proteins are uniquely sensitive. This study further supports the perspective that transcript and protein expression data are not interchangeable ([@evv132-B49]) and that the biological signals accessible by each molecule should be considered when designing studies of comparative molecular expression.

Materials and Methods
=====================

Samples
-------

Frozen human brain samples (aged 34--51 years) were obtained from the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland (Baltimore, MD) and were free from neurological disorders. Frozen brain samples from adult common chimpanzees, *Pan troglodytes* (aged 23 to 35 years), were obtained from the Alamogordo Primate Facility (Holloman Airforce Base, Alamogordo, NM). The chimpanzees had been cared for according to Federal and Institutional Animal Care and Use guidelines and died of natural causes. ACC and CN were sampled from three adult humans and three adult chimpanzees. ACC samples were dissected near the genu of the corpus callosum, corresponding to Brodmann's area 24, and contained all neocortical layers and a small amount (\<10%) of underlying white matter. CN samples were dissected from the head of the caudate and contained no surrounding white matter. All samples were divided into two pieces for RNA sequencing and for quantitative proteomics, respectively. The tissue was collected and stored at −80 °C with postmortem intervals of less than 8 h to diminish degradation of proteins. A detailed summary of the sample, including ages and sexes of individuals, is provided in [supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1) online.

Transcriptome and Proteome Generation
-------------------------------------

Total RNA was isolated with an RNeasy kit (Qiagen, Valencia, CA) including a DNaseI treatment step. Four micrograms of total RNA was used to make each transcriptome library. Library construction was performed with the Illumina Tru-Seq kit (Illumina, San Diego, CA). Libraries were sequenced at the Institute for Genome Sciences & Policy and the Genome Sequencing & Analysis Core Facility at Duke University. Approximately 30 million 50-bp sequences were produced for each library. Orthologous gene models for each species were constructed using methods described previously ([@evv132-B4]). Sequences were mapped to the species-specific genomes, human (hg19) and chimpanzee (panTro3) ([@evv132-B47]). Gene transcripts were quantified in counts per million using HT-Seq (<http://www.huber.embl.de/users/anders/HTSeq/doc/overview.html>, last accessed July 22, 2015), and the data were normalized using edgeR ([@evv132-B38]).

The Proteomics Core Facility at Duke University prepared and performed LC/MS/MS on all the samples for protein identification and quantification. Details regarding these procedures and their reproducibility can be found in the [supplementary text](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1) and [figures S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1) and [S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1) online. Proteins were quantified in summed ion intensity, and the resulting proteomic data set was normalized using the same method as the genomic data.

Data Set Construction
---------------------

The Synergizer (<http://llama.mshri.on.ca/synergizer/translate/>, last accessed July 22, 2015) was used to match proteins back to their parent transcripts by searching the Ensembl database. This produced a list of 791 transcript--protein pairs. Several genes matched to more than one protein product, typically different isoforms of the same protein. In this case, the protein with the highest Teller score (confidence rating of the protein assignment) and an assigned function in the UniProt database (<http://www.uniprot.org>, last accessed July 22, 2015) was kept in the data set. For inclusion in this study, each human protein had to have a chimpanzee homolog (Uniprot identification ending with "PANTR"). The resulting list contained 715 homologous proteins, each paired to their theoretical transcript parent. For simplicity, we referred to proteins by their human identifier (Uniprot identification ending with "HUMAN").

Variation in Gene and Protein Expression
----------------------------------------

We explored intraspecific variation of gene and protein expression by finding the coefficient of variation (CV) across the three individuals per species. Because CVs have no units and are normalized to the mean of the species-specific expression level, interindividual variance can be compared between the two sets of molecular data. Mann--Whitney tests were performed to examine whether the central tendencies of the interindividual CVs of the molecules differed, and Kolmogorov--Smirnov tests were used to determine whether their distributions differed in terms of shape.

Differential Expression
-----------------------

To explore possible functional implications of transcript and protein expression, we performed categorical enrichment analyses on Gene Ontology (GO) categories of biological function ([@evv132-B13]) using pyEnrichment (<https://github.com/ofedrigo/pyEnrichment>, last accessed July 22, 2015). The background was all of the transcripts or proteins of the data set. Significance levels for difference in expression were determined with a modified exact test similar to Fisher's exact test.

Regression Analyses
-------------------

The relationship between the expression levels of parent transcripts and their protein products was explored using species means. We performed ordinary least squares (OLS) regressions, which account for error present in the *y* dimension ([@evv132-B41]). We opted against performing reduced major axis (RMA) regressions, which purports to diminish the variance along the *x*- and *y* axes ([@evv132-B42]). Some authors have suggested that the error accounted for by RMA along the *x* axis can originate from biological sources in addition to error implicit in measurement ([@evv132-B21]; [@evv132-B15]). All regressions were calculated using SMATR package (version 3.3) for R (version 3.0.1) (Falster DS, Warton DI, and Wright IJ, <https://github.com/dfalster/smatr/>, last accessed July 22, 2015). To explore whether transcript and proteins pairs supporting disparate biological functions differ in their scaling relationships, we ran OLS regressions on the average species expression of transcripts and proteins supporting GO categories of biological function (484 categories in ACC, 485 in CN).

Results
=======

Genomic and Proteomic Data Sets
-------------------------------

In total, we assayed expression from 12,443 gene transcripts in the ACC and 11,787 genes in the CN of humans and chimpanzees. The proteomic data set was based on the expression of 8,775 peptides from 1,337 proteins. The quantitative data for each sample at the peptide and protein-level can be found in [supplementary data set S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1) online. This file also contains individual expression levels for each transcript and protein, the species mean, standard deviation, and interindividual CV.

Because our goal was to assess the biological signals from transcripts that could be compared directly with their corresponding proteins, and vice versa, we constructed a "paired" data set, consisting of theoretical transcript parents each paired to a single protein product (522 pairs in the ACC, 499 in the CN once one outlier was removed from the analysis in each region \[see below\]). However, we performed the same analyses on the "unpaired data sets," which consisted of the entire sets of transcripts and proteins that were quantified and had homologs in the chimpanzee. Results and discussion of the unpaired data set can be found in the [supplementary text](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1) online. [Table 1](#evv132-T1){ref-type="table"} lists the numbers of transcripts and proteins in each of these data sets. Table 1The Number of Transcripts and Proteins that Are Uniquely Identified or Those that Can Be Paired As a Single Gene Transcript with a Protein ProductACCCNTotal transcripts12,44311,787Uniquely identified transcripts, "unpaired"11,92011,287Total proteins715715Uniquely identified proteins, "unpaired"192215"Paired" transcripts and proteins523500

As expected, many transcripts did not have a corresponding protein that could be measured (11,920 in ACC and 11,287 in CN). However, a surprisingly large number of proteins were analyzed that did not have matching RNA transcripts detected (192 in ACC and 215 in CN). The gene models for each of these transcripts were included in the list of orthologous protein-coding regions that we attempted to detect using RNA-Seq (see Materials and Methods). In order to further explore this discrepancy between data sets, we performed an enrichment analysis on these proteins using DAVID Bioinformatics Resource (version 6.7; <http://david.abcc.ncifcrf.gov>, last accessed July 22, 2015). We found that many of the proteins that did not have a corresponding transcript analyzed were involved in mitochondrial function and metabolism ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1) online). Although this result is somewhat surprising because both transcripts and proteins supporting metabolism are known to be rather stable molecules within mammalian cells ([@evv132-B39]), we suspect that rapid postmortem degradation of mRNAs associated with metabolic functions may have caused this effect ([@evv132-B12]).

Variation in Transcript and Protein Expression
----------------------------------------------

We examined interindividual CVs in transcript and protein expression to determine how the variation in expression levels may differ between transcripts and proteins. The frequency distributions of the CVs for the paired data set of each of these regions are shown in [figure 1](#evv132-F1){ref-type="fig"} and summarized in [table 2](#evv132-T2){ref-type="table"}. In each case, the variation in the expression levels of the transcripts was significantly greater than that of the proteins, and the shape of the distribution of CVs between genomic and proteomic data differed significantly. These data indicate that the expression of proteins is less variable and more constrained than the expression of transcripts in both species and in both brain regions, a result that is consistent with research from primate cell lines ([@evv132-B24]). F[ig]{.smallcaps}. 1.---The frequency bar graphs of interindividual CVs for transcript (blue) and protein (red) expression in ACC and CN in humans and chimpanzees using the paired data sets. The overlap between these two distributions appears as a darker (purplish) color. The results of Mann--Whitney tests comparing the central tendencies of transcript and protein expression are provided. Table 2The Results of Mann--Whitney and Kolmogorov--Smirnov Tests of Interindividual CVs between Gene and Protein Expression, Regions of the Brain, and Species in the Paired Data SetMann--WhitneyKolmogorov--SmirnovComparison*UP* Value*DP* ValueGenes versus proteinsHuman ACC2.6 x 10^5^\<0.0010.76\<0.001Human CN2.1 x 10^5^\<0.0010.60\<0.001Chimpanzee ACC2.0 x 10^5^\<0.0010.39\<0.001Chimpanzee CN2.3 x 10^5^\<0.0010.71\<0.001ACC versus CNHuman genes1.2 x 10^5^\<0.010.090.03Chimpanzee genes2.0 x 10^5^\<0.0010.46\<0.001Human proteins1.7 x 10^5^\<0.0010.21\<0.001Chimpanzee proteins1.5 x 10^5^\<0.0010.120.001Humans versus chimpanzeesGenes in ACC2.0 x 10^5^\<0.0010.36\<0.001Genes in CN9.5 x 10^4^\<0.0010.19\<0.001Proteins in ACC1.1 x 10^5^\<0.0010.14\<0.001Proteins in CN1.2 x 10^5^0.700.040.90

We explored whether there were differences in the variance of molecular expression between ACC and CN. A greater median variance in transcript expression was found in human ACC compared with human CN, whereas chimpanzee CN displayed a greater median variance than chimpanzee ACC. Other studies have found the transcriptional expression of the basal ganglia to be less variable compared to the neocortex of humans and chimpanzees ([@evv132-B23]; [@evv132-B16]), so it is surprising to find as much variation in the expression of transcripts within the chimpanzee's CN. Interregional protein expression in humans and chimpanzees displayed a greater median variance in CN in both species. Furthermore, the shape of the distribution of interregional variance in gene transcript expression and protein expression was the same in the ACC and CN. A relatively high level of variation in protein expression in the CN compared with the ACC in both species was unexpected. Although gene transcript expression is relatively stable in the basal ganglia compared with the neocortex ([@evv132-B23]), our results suggest that the opposite may be true for proteins.

There was no clear pattern in interindividual expression between humans and chimpanzees in either molecule or region of the brain. The comparison of variation in the expression of transcripts between species revealed that humans exhibit a greater median variance in ACC, but chimpanzees display a greater median variance in the CN. The shapes of these distributions in variance were also different. Although chimpanzees displayed a greater median variance in protein expression in ACC, the variances in protein expression within the CN were indistinguishable between the two species. Similarly, although the shape of the distribution in variance of protein expression differed between human and chimpanzee ACC, CN exhibited a similar shape of distribution of variance between the two species. These results indicate that the variation in molecular expression is not systematically greater in either species regardless of whether transcripts or proteins are considered. However, the ACC and CN produced different results in these analyses, suggesting that the expression of both transcripts and proteins is influenced by region-specific mechanisms that may result in specialized cognitive functions of the ACC and CN.

Differential Expression of Genes and Proteins
---------------------------------------------

We compared the mean expression levels of transcripts and proteins in ACC and CN for each species separately by OLS regression analysis using log-transformed data. We discovered one outlier transcript in each comparison: *FHDC1* in human ACC and *AUH* in chimpanzee CN. Although their expression levels were within the range of other proteins (for ACC and CN in both species, Shapiro--Wilk test *P* value \< 0.0001; human ACC variability = 5.00 ± 0.62; human CN variability = 5.01 ± 0.61; chimpanzee ACC variability = 4.97 ± 0.64; chimpanzee CN variability = 5.01 ± 0.62), both displayed much lower transcript expression levels than the rest of the transcript--protein pairs (*FHDC1* in the human ACC = median − lower quartile \[Q1\] \* 11.57; *AUH* in the chimpanzee CN = median − Q1 \* 13.07). Because we could not ascertain that their low transcript expression levels were due to biological variation and not to measurement error, *AUH* and *FHDC1* were excluded from further analyses.

From the paired data set, we found 36 of 523 transcripts to be DE between humans and chimpanzees in the ACC (FDR ≤ 0.05) and 42 of the 523 proteins to be DE in the same region. In the CN, 33 of the 500 transcripts were DE (FDR ≤ 0.05), and 37 proteins were DE. We performed enrichment analyses on the paired data set to determine whether the expression of transcripts reflected the same biological signals as their protein products. Transcripts supporting 51 categories of biological function in ACC and 22 in CN were DE between humans and chimpanzees (minimum of three genes per category, *q* ≤ 0.05). Biological functions that were DE among the transcripts in the ACC could be broadly categorized as supported neuronal communication, ion transport, cellular regulatory processes, and biosynthesis ([fig. 2](#evv132-F2){ref-type="fig"}). In the CN, biological functions that were DE included those involved in oxidative metabolism, ion transport, cellular regulatory processes, and immune response. The list of the significant results of differential expression analyses of the paired data set can be found in [table 3](#evv132-T3){ref-type="table"}. F[ig]{.smallcaps}. 2.---DE gene transcripts and protein products between humans and chimpanzees in GO categories of biological function for the paired data set. The DE categories of transcripts (upper row) are depicted by blue circles for the ACC (upper left) and CN (upper right). The DE categories of proteins (lower row) are depicted by red circles for the ACC (lower left) and CN (lower right). The circles represent categories of biological function, which contain gene transcripts that are DE between the two species. The size of the circle represents the number of genes with a *q* value below the maximum threshold (the gray circles in the bottom left corners provide a guide). The darkness of the circle represents the level of significance (as indicated by the scales, which are the same for both ACC and CN). Aside from the degree of overlap of functional categories, the arrangement of the circles has no meaning. The minimum thresholds are different for genes (in ACC, minimum of five genes per category, *q* ≤ 0.05; in CN, minimum of three genes per category, *q* ≤ 0.05) and proteins (in ACC, minimum of five proteins per category, *q* ≤ 0.05; in CN minimum of three proteins per category, *q* ≤ 0.05). Table 3DE Gene Transcripts and Protein Products between Humans and Chimpanzees in the GO Category of Biological Function in ACC and CN for the Paired Data Set (Minimum Three Molecules per Category, *q* ≤ 0.05)GO Biological Process Category*q* ValueTotal OccurrencesGO Biological Process Category*q* ValueTotal Occurrences**DE transcripts between humans and chimpanzees in the ACCDE proteins between humans and chimpanzees in the ACC**Nitrogen compound biosynthetic process2.10E-039Central nervous system development4.18E-037Nitric oxide mediated signal transduction5.25E-033Cellular protein complex assembly4.33E-037Antiapoptosis7.67E-039Protein polymerization7.13E-036Cell--cell signaling8.41E-0315Cellular macromolecule catabolic process8.93E-0325Synaptic transmission8.41E-0315Hemostasis9.40E-034Sodium ion transport8.44E-038Regulation of body fluid levels9.40E-034Glutamine family amino acid catabolic process9.55E-037Carbohydrate catabolic process1.01E-0216Regulation of neurotransmitter levels1.04E-026Cellular carbohydrate catabolic process1.01E-0216Cation transport1.11E-0224Oxidation reduction1.09E-0254Learning1.26E-025Protein complex assembly1.26E-0217Neurotransmitter biosynthetic process1.35E-023Cellular macromolecular complex assembly1.48E-0214Metal ion transport1.35E-0219Cellular macromolecular complex subunit organization1.48E-0214Response to light stimulus1.49E-023Cellular component assembly1.48E-0225Nervous system development1.51E-0220Alcohol catabolic process1.52E-0215Hemostasis1.55E-024Glucose catabolic process1.52E-0215Regulation of body fluid levels1.55E-024Hexose catabolic process1.52E-0215Amine biosynthetic process1.71E-025Monosaccharide catabolic process1.52E-0215Catecholamine metabolic process1.72E-023Macromolecular complex subunit organization1.54E-0226Dopamine metabolic process1.72E-023Macromolecular complex assembly1.64E-0224Phenol metabolic process1.72E-023Monosaccharide metabolic process1.64E-0221Monovalent inorganic cation transport1.76E-0215Cellular carbohydrate metabolic process1.69E-0228Amino acid transport1.79E-025Cellular aromatic compound metabolic process1.73E-029Carboxylic acid transport1.79E-025Glycolysis1.76E-0213Organic acid transport1.79E-025Cellular alcohol metabolic process1.78E-0227Regulation of neurological system process1.85E-024Glucose metabolic process1.83E-0220Regulation of synaptic transmission1.85E-024Hexose metabolic process1.83E-0220Regulation of transmission of nerve impulse1.85E-024Nuclear transport1.86E-023Positive regulation of nucleobase, nucleoside, nucleotide, and nucleic acid metabolic process2.04E-025Nucleocytoplasmic transport1.86E-023Negative regulation of apoptosis2.12E-0211Protein homooligomerization2.20E-024Negative regulation of programmed cell death2.12E-0211Protein oligomerization2.20E-024Cellular aromatic compound metabolic process2.33E-029Monocarboxylic acid metabolic process2.37E-0216Muscle contraction2.47E-024Aromatic compound catabolic process2.62E-023Posttranslational protein modification2.57E-0227Cellular catabolic process2.63E-0262Neurotransmitter transport2.78E-028Sensory perception of light stimulus2.74E-025Nitric oxide biosynthetic process2.85E-024Visual perception2.74E-025**DE transcripts between humans and chimpanzees in the ACCDE proteins between humans and chimpanzees in the ACC**Nitric oxide metabolic process2.85E-024Neurotransmitter metabolic process3.09E-024Memory2.97E-023Cellular response to stress3.36E-023Cell-substrate adhesion3.38E-024Carboxylic acid catabolic process3.54E-027Negative regulation of RNA metabolic process3.39E-023Fatty acid catabolic process3.54E-027Negative regulation of transcription, DNA-dependent3.39E-023Organic acid catabolic process3.54E-027Neurofilament cytoskeleton organization3.42E-023Macromolecule catabolic process3.74E-0227Glutamine family amino acid metabolic process3.45E-028Carbohydrate metabolic process3.77E-0238Positive regulation of immune system process3.49E-023Amine transport4.32E-027Behavior4.13E-0215Response to inorganic substance4.45E-023Muscle system process4.16E-025Response to metal ion4.45E-023Learning or memory4.17E-029Muscle development4.65E-023Cell-matrix adhesion4.30E-023Response to abiotic stimulus4.30E-026Regulation of neuronal synaptic plasticity4.35E-023Regulation of synaptic plasticity4.35E-023System development4.81E-0227**DE transcripts between humans and chimpanzees in the CNDE proteins between humans and chimpanzees in the CN**Nitric oxide mediated signal transduction3.48E-043Muscle development1.41E-023Carbohydrate metabolic process1.79E-0335Lipid metabolic process1.57E-0227Response to wounding2.62E-034MRNA metabolic process1.86E-024Regulation of axonogenesis4.05E-035Coenzyme metabolic process2.36E-0222Regulation of cell development4.05E-035Cofactor metabolic process2.36E-0222Regulation of cell morphogenesis involved in differentiation4.05E-035Sensory perception of light stimulus2.39E-024Oxidation reduction1.16E-0252Visual perception2.39E-024Regulation of cell projection organization1.41E-026Anatomical structure homeostasis2.82E-023Regulation of nervous system development1.41E-026Tissue homeostasis2.82E-023Regulation of neurogenesis1.41E-026Intermediate filament cytoskeleton organization2.92E-023Regulation of neuron differentiation1.41E-026Intermediate filament-based process2.92E-023Arginine catabolic process1.91E-023Neurofilament cytoskeleton organization2.92E-023Arginine metabolic process1.91E-023Negative regulation of microtubule depolymerization3.83E-024Regulation of axon extension2.10E-024Negative regulation of microtubule polymerization or depolymerization3.83E-024Hydrogen transport2.48E-027Regulation of microtubule depolymerization3.83E-024Proton transport2.48E-027Regulation of microtubule polymerization or depolymerization3.83E-024Inflammatory response2.88E-023Regulation of microtubule-based process3.83E-024Energy coupled proton transport, against electrochemical gradient4.00E-023Adult behavior4.14E-023Cell recognition4.65E-023Adult locomotory behavior4.14E-023Cellular lipid catabolic process4.74E-028Membrane fusion4.54E-024Macromolecule localization4.88E-023Hemostasis4.80E-024Protein localization4.88E-023Regulation of body fluid levels4.80E-024

A similar number of biological functions met our threshold criteria for differential expression between humans and chimpanzees when analyzing proteins as compared with transcripts (46 in ACC and 22 in CN; minimum of 3 proteins per category, *q* ≤ 0.05). Using the listed thresholds, we found that a lower percentage of transcripts and proteins were DE between humans and chimpanzees in CN compared with ACC (transcripts: 10.3% in ACC, 4.4% in CN; proteins: 8.8% in ACC, 4.4% in CN). Importantly, biological functions that were DE in the proteins between humans and chimpanzees in the ACC included those supporting oxidative metabolism, anaerobic metabolism and biosynthesis, perception, and immune response ([fig. 2](#evv132-F2){ref-type="fig"}). In the CN, DE biological functions supported biosynthesis, ion homeostasis, perception, and immune response.

Comparing the biological signals accessible by transcripts and proteins within the same brain regions of interest reveals that transcripts are uniquely indicative of cellular regulatory processes, neuronal communication, and immune response, whereas proteins exhibit differences related to organization of the cytoskeleton and molecular catabolism. Our results indicate variability in the brain tissue-specific biological processes that are assessed by either transcriptomic or proteomic analyses, and these findings are largely consistent with the more general functional characteristics attributed to transcripts and proteins with regard to their molecular stability in cell lines ([@evv132-B39]).

Covariance of Gene and Protein Expression
-----------------------------------------

OLS regressions revealed weak, but significant, relationships between gene expression and protein expression in human ACC (β = 0.16, *y*-intercept = 4.64, *R*^2^= 0.03, *P* \< 0.01, slope confidence interval \[CI\] = 0.08--0.23), human CN (β = 0.15, *y*-intercept = 4.69, *R*^2^= 0.03, *P* \< 0.01, slope CI = 0.07--0.21), chimpanzee ACC (β = 0.17, *y*-intercept = 4.58, *R*^2^= 0.04, *P* \< 0.01, slope CI = 0.10--0.23), and chimpanzee CN (β = 0.14, *y*-intercept = 4.70, *R*^2^= 0.03, *P* \< 0.01, slope CI = 0.06--0.21). These four regression slopes are significantly less than 1 (*P* \< 0.01), indicating a lack of equivalency between the expression levels of genes and proteins. These slopes were subsequently used in comparisons with the scaling of categories of GO biological function (see below) and will hereafter be referred to as "baseline slopes."

To explore whether there is variability in the relationships of transcripts and proteins that support disparate biological functions, we performed separate OLS linear regressions on the expression of transcript--protein pairs from categories of biological function with ten or more transcript/protein pairs per category (484 categories in ACC, 485 in CN; [supplementary table S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv132/-/DC1) online). Although most categories had a slope similar to that of baseline slopes, the range of slopes was highly variable (human ACC interquartile range \[IQR\] = 0.05--0.33, range = −0.37 to 0.86; human CN IQR = 0.00--0.28, range = −0.42 to 1.06; chimpanzee ACC IQR = 0.11--0.36, range = −0.62 to 1.20; chimpanzee CN IQR = 0.00--0.27, range = −0.46 to 1.00). These results reveal that different relationships exist between transcript and protein expression depending on biological function. Moreover, a pattern emerged in the data, which to our knowledge has not been reported elsewhere. For biological function categories that deviated significantly from the region- and species-specific baseline slope (*P* ≤ 0.05), we plotted the correlation (R^2^) between gene and protein expression against the *P* value of the categorical slope's deviation from the baseline. The more the slope of a category of biological function deviated from the baseline, the higher the correlation between gene and protein expression ([fig. 3](#evv132-F3){ref-type="fig"}). In each region and species, biological functions that support this observation are involved in transcription, protein modification, and metabolic processes. It is noteworthy that each of these biological processes affects protein abundance (or, in the case of protein modification, how detectable the proteins are to analysis). F[ig]{.smallcaps}. 3.---Linear regressions of the *R*^2^ and *P* values of the GO categories of biological function that were significantly different from their baseline slopes. GO biological categories (*n* ≥ 10 gene transcript--protein product pairs) that were significantly different (*P* ≤ 0.05) from the local transcript and protein expression baseline slopes (human ACC β = 0.16, CN β = 0.15; chimpanzee ACC β = 0.17, CN β = 0.14) are plotted with their *R*^2^ values against their *P* value for both regions of interest in humans and chimpanzees. White circles mean that the biological category had a greater slope than the baseline slope, whereas black circles represent a negative slope. The relationship among the points is found by OLS.

Discussion
==========

We found an overall weak but significant relationship between the expression levels of gene transcripts and protein products in ACC and CN in humans and chimpanzees. These results support other studies in which gene expression levels proved to be poor predictors of protein expression levels in human ([@evv132-B37]; [@evv132-B24]; [@evv132-B53]), and chimpanzee and macaque cell lines ([@evv132-B24]). To some extent, a direct correspondence between transcript and protein expression is not expected because the efficiency of translation and rate of protein degradation affect protein availability, causing protein expression levels to deviate from what would be predicted based on transcript abundance ([@evv132-B7]). Moreover, it was recently reported that the effect of some regulatory genetic variants may be buffered at the protein level, despite showing robust effects at the level of the transcript ([@evv132-B1]). We found that there was not a systematic manner by which expression levels of transcripts related to their protein products. The lack of a predictive relationship between transcript and protein expression is a trait shared by both humans and chimpanzees in both ACC and CN. Additionally, our finding of lower interindividual variation in protein expression compared with transcript expression in the brain implies that translation is under stronger stabilizing selection than transcription in both of these species ([@evv132-B39]; [@evv132-B24]). However, despite the smaller amount of variation among proteins across individuals, a proportionally greater number of proteins are DE between humans and chimpanzees. This finding implies that even very small differences in protein abundance may be associated with substantial phenotypic divergence.

Our analysis of differential gene and protein expression in the human and chimpanzee brain showed that quite divergent results are obtained when considering the abundances of gene transcripts compared with proteins. Although transcripts are uniquely reflective of cellular regulatory processes, neuronal communication, and immune response, proteomic analyses are better able to detect differences in organization of the cytoskeleton and molecular catabolism. The fact that proteins related to cell structure are DE between species is not surprising because high-throughput proteomic methods tend to measure the most abundant proteins, omitting those that are less prevalent, so to some extent this result is a function of a limitation in proteomic techniques. However, these results are important as they emphasize that different biological signatures are accessible between humans and chimpanzees depending on what type of molecule is examined. It is also worth considering that transcripts degrade at variable rates that can be tied to biological function, with transcripts supporting immune function, for example, degrading very quickly ([@evv132-B12]). However, whether proteins supporting different functional processes degrade at different rates in postmortem tissue remains unknown.

We found divergent molecular signatures in DE between ACC and CN. Although neuronal communication, biosynthesis, and carbohydrate metabolism are DE in molecular expression from the ACC, oxidative metabolism, immune response and perception are more divergent in CN. In an analysis of gene transcript coexpression networks in humans and chimpanzees, ACC and CN were found to share a similar pattern of expression, potentially indicative of the neural connections between these two regions ([@evv132-B32]). Although our investigation does not include an outgroup by which to interpret the direction of selection, the biological implications of DE of transcripts and proteins supporting these biological functions should be considered. Specifically, DE of molecules supporting neuronal communication and carbohydrate metabolism in the ACC may underlie alterations in synaptic transmission and energy needs between human and chimpanzee ACC function ([@evv132-B48]). Notably, these DE categories of biological function are similar to those found to be enriched with *cis*-regulatory sequences in humans compared with chimpanzees, indicating that this type of regulation may be particularly effective within the ACC ([@evv132-B17]). Differential expression of molecules supporting oxidative metabolism and behavior and perception in CN may underlie the connectivity and integration of sensory information involved in language production in humans ([@evv132-B8]).

Importantly, this work identifies categories of biological function whose constituent molecules may be the targets of species-specific posttranscriptional regulation. Our results indicate that the relationship between transcript and protein abundance differs with functional category. Not only did we find a broad variation of slopes in our regression analyses of protein expression on gene transcript expression, but also genes and proteins supporting several functional categories, including those that support translation, protein modifications, biosynthesis of macromolecules, and cellular adhesion, have a stronger correlation than the typical transcript parent/protein product pair. Because the expression of genes within these categories of biological function suggests regulation by a coordinated mechanism, transcript--protein pairs within these categories may offer potential places to explore posttranslational regulation.

There are at least three directions where our knowledge of comparative molecular biology of the human brain is lacking as it relates to other primates. First, it remains unknown the extent to which the relationship between transcript expression and protein expression differs across disparate regions of the brain. Although fewer differences in transcript abundance are seen across specific regions of the cerebral cortex than between the cortex, CN, and cerebellum ([@evv132-B23]; [@evv132-B32]), the lack of correlated expression between transcripts and proteins draws into question whether protein expression alone would follow a similar trend. Although layer-specific analyses of gene expression patterns in the primate cerebral cortex are now possible ([@evv132-B3]; [@evv132-B16]), relatively little is known about the spatial specificity of protein expression. Such analyses of regional transcriptomic and proteomic expression patterns in the brains of humans (and nonhuman primates) are particularly important in light of new evidence that individual neurons carry different genomes comprised transcript sequence repeats or deletions ([@evv132-B30]) and that sampling large regions of cortex may dilute molecular signals unique to cortical layers or individual cells. Second, because regulation of transcription expression is dynamic over the course of the lifetime ([@evv132-B29]; [@evv132-B43], [@evv132-B44]; [@evv132-B50]), a better understanding of how transcript and protein expression vary throughout the lifetime, to support neurodevelopmental processes ([@evv132-B28], should be appreciated. Third, although gene transcripts have been assessed using coexpression networks ([@evv132-B31]; [@evv132-B51]), the lack of coordination between gene transcripts and protein expression indicates that similar work could be a fruitful contribution to our understanding of the networks of interacting proteins underlying phenotypes.

Conclusion
==========

In summary, our work provides novel insights into gene and protein expression in the brains of humans and chimpanzees. The low correspondence between transcript and protein expression levels means that different biological signals are reflected in the analysis of one molecule compared with the other. Although the relationship between gene and protein expression is weak overall, we found different, and sometimes stronger, relationships when examining genes and proteins that support specific biological functions. Gene transcript and protein pairs that display different patterns of expression compared with the rest of the transcriptome and proteome may assist in directing future studies in finding regulatory elements that are important in determining the phenotype of the human brain.
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